310 related articles for article (PubMed ID: 10477323)
1. In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers.
Lake OA; Olling M; Barends DM
Eur J Pharm Biopharm; 1999 Jul; 48(1):13-9. PubMed ID: 10477323
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
Jantratid E; Prakongpan S; Amidon GL; Dressman JB
Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
[TBL] [Abstract][Full Text] [Related]
3. IVIVC approach based on carbamazepine bioequivalence studies combination.
González-García I; Mangas-Sanjuan V; Merino-Sanjuán M; Álvarez-Álvarez C; Díaz-Garzón Marco J; Rodríguez-Bonnín MA; Langguth T; Torrado-Durán JJ; Langguth P; García-Arieta A; Bermejo M
Pharmazie; 2017 Aug; 72(8):449-455. PubMed ID: 29441903
[TBL] [Abstract][Full Text] [Related]
4. Discriminatory dissolution method for quality control measurements of carbamazepine immediate release tablets based on in vitro--in vivo investigations.
Xu C; Zou M; Wang Y; Liu Y; Yan J; Wu Y; Cheng G
Drug Dev Ind Pharm; 2012 Jun; 38(6):679-88. PubMed ID: 21988132
[TBL] [Abstract][Full Text] [Related]
5. A single and multiple dose bioavailability study with carbamazepine 400 mg retard tablets with reference to enzyme autoinduction and circadian time differences.
Hoffmann C; Zschiesche M; Franke G; Hoffmann A; Terhaag B; Möritz KU; Siegmund W
Int J Clin Pharmacol Ther; 1997 Nov; 35(11):496-503. PubMed ID: 9401830
[TBL] [Abstract][Full Text] [Related]
6. Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation.
Kovacević I; Parojcić J; Homsek I; Tubić-Grozdanis M; Langguth P
Mol Pharm; 2009; 6(1):40-7. PubMed ID: 19248231
[TBL] [Abstract][Full Text] [Related]
7. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutical characterization of carbamazepine immediate release tablets. In vitro-in vivo comparison.
Homsek I; Parojcic J; Cvetkovic N; Popadic D; Djuric Z
Arzneimittelforschung; 2007; 57(8):511-6. PubMed ID: 17915636
[TBL] [Abstract][Full Text] [Related]
9. Towards a universal dissolution medium for carbamazepine.
El-Massik MA; Abdallah OY; Galal S; Daabis NA
Drug Dev Ind Pharm; 2006 Aug; 32(7):893-905. PubMed ID: 16908426
[TBL] [Abstract][Full Text] [Related]
10. Existing and new criteria for bioequivalence evaluation of new controlled release (CR) products of carbamazepine.
Bialer M; Arcavi L; Sussan S; Volosov A; Yacobi A; Moros D; Levitt B; Laor A
Epilepsy Res; 1998 Nov; 32(3):371-8. PubMed ID: 9839777
[TBL] [Abstract][Full Text] [Related]
11. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
12. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
Gordon MS; Chowhan Z
Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
[TBL] [Abstract][Full Text] [Related]
13. Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model.
Vuletić L; Khan MZI; Špoljarić D; Radić M; Cetina-Čižmek B; Filipović-Grčić J
Pharm Res; 2018 Jun; 35(8):163. PubMed ID: 29934663
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T
Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541
[TBL] [Abstract][Full Text] [Related]
15. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
[TBL] [Abstract][Full Text] [Related]
16. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions.
Elshafeey AH; Elsherbiny MA; Fathallah MM
Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850
[TBL] [Abstract][Full Text] [Related]
17. Does the Ethnic Difference Affect the Pharmacokinetics of Favipiravir? A Pharmacokinetic Study in Healthy Egyptian Volunteers and Development of Level C In-vitro In-vivo Correlation.
Bendas ER; Rezk MR; Badr KA
Drug Res (Stuttg); 2023 Jul; 73(6):349-354. PubMed ID: 37094796
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
Cho HY; Yoon H; Park GK; Lee YB
Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro study of six carbamazepine products.
Mittapalli PK; Suresh B; Hussaini SS; Rao YM; Apte S
AAPS PharmSciTech; 2008; 9(2):357-65. PubMed ID: 18431676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
